PAR-25-053-Full-Announcement.html

This document is a Notice of Funding Opportunity (NOFO) for the Translational Neural Devices (R61/R33 - Clinical Trial Optional) federal grant program. The purpose of this NOFO is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic and diagnostic devices for disorders affecting the nervous or neuromuscular systems.

Key details include:

• Funding Instruments: Grant
• Eligible Applicants: Various organization types including non-profits, government entities, small businesses, and higher education institutions
• Funding Activity Categories: Health
• Supported activities: Implementation of clinical prototype devices, non-clinical safety/efficacy testing, design verification/validation, obtaining Investigational Device Exemption (IDE) or Institutional Review Board (IRB) approval, and a subsequent small clinical study
• This is a milestone-driven cooperative agreement program involving NIH program staff
• The program is administered by the Department of Health and Human Services National Institutes of Health under the Extramural Research Programs in the Neurosciences and Neurological Disorders grant program (CFDA 93.853).